miR-22 in cardiac remodeling and disease
- PMID: 25218673
- PMCID: PMC4171194
- DOI: 10.1016/j.tcm.2014.07.005
miR-22 in cardiac remodeling and disease
Abstract
Regulation of gene expression during cardiac development and remodeling is very complicated, involving epigenetic, transcriptional, post-transcriptional, and translational regulation. Our understanding of the molecular mechanisms underlying cardiac remodeling is still far from complete. MicroRNAs are a class of small non-coding RNAs that have been shown to play critical roles in gene regulation in cardiovascular biology and disease. microRNA-22 (miR-22) is an evolutionally conserved miRNA that is highly expressed in the heart. Recent studies uncovered miR-22 as an important regulator for cardiac remodeling. miR-22 modulates the expression and function of genes involved in hypertrophic response, sarcomere reorganization, and metabolic program shift during cardiac remodeling. In this review, we will focus on the recent findings of miR-22 in cardiac remodeling and the therapeutic potential of this miRNA in the treatment of related defects resulting from adverse cardiac remodeling.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
MicroRNAs in cardiac remodeling and disease.J Cardiovasc Transl Res. 2010 Jun;3(3):212-8. doi: 10.1007/s12265-010-9165-y. Epub 2010 Feb 17. J Cardiovasc Transl Res. 2010. PMID: 20560042 Review.
-
Role of microRNAs in cardiac remodeling and heart failure.Cardiovasc Drugs Ther. 2011 Apr;25(2):171-82. doi: 10.1007/s10557-011-6289-5. Cardiovasc Drugs Ther. 2011. PMID: 21431305 Review.
-
miRNA-1: functional roles and dysregulation in heart disease.Mol Biosyst. 2014 Nov;10(11):2775-82. doi: 10.1039/c4mb00338a. Mol Biosyst. 2014. PMID: 25177824 Review.
-
Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling.Trends Cardiovasc Med. 2016 Apr;26(3):209-18. doi: 10.1016/j.tcm.2015.07.002. Epub 2015 Jul 17. Trends Cardiovasc Med. 2016. PMID: 26391345 Free PMC article. Review.
-
MicroRNA-200a-3p Is a Positive Regulator in Cardiac Hypertrophy Through Directly Targeting WDR1 as Well as Modulating PTEN/PI3K/AKT/CREB/WDR1 Signaling.J Cardiovasc Pharmacol. 2019 Nov;74(5):453-461. doi: 10.1097/FJC.0000000000000732. J Cardiovasc Pharmacol. 2019. PMID: 31651553
Cited by
-
MicroRNAs in Cancer and Cardiovascular Disease.Cells. 2022 Nov 10;11(22):3551. doi: 10.3390/cells11223551. Cells. 2022. PMID: 36428980 Free PMC article. Review.
-
Pericardial Fluid Accumulates microRNAs That Regulate Heart Fibrosis after Myocardial Infarction.Int J Mol Sci. 2024 Jul 30;25(15):8329. doi: 10.3390/ijms25158329. Int J Mol Sci. 2024. PMID: 39125899 Free PMC article.
-
Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention.Front Physiol. 2018 Jul 25;9:955. doi: 10.3389/fphys.2018.00955. eCollection 2018. Front Physiol. 2018. PMID: 30090067 Free PMC article.
-
MicroRNA Profiling of HL-1 Cardiac Cells-Derived Extracellular Vesicles.Cells. 2021 Jan 30;10(2):273. doi: 10.3390/cells10020273. Cells. 2021. PMID: 33573156 Free PMC article.
-
Editorial: Cardiac Remodeling: New Insights in Physiological and Pathological Adaptations.Front Physiol. 2017 Sep 26;8:751. doi: 10.3389/fphys.2017.00751. eCollection 2017. Front Physiol. 2017. PMID: 29018366 Free PMC article. No abstract available.
References
-
- Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358:1370–1380. - PubMed
-
- Lagos-Quintana M, et al. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853–858. - PubMed
-
- Lau NC, et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001;294:858–862. - PubMed
-
- Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001;294:862–864. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical